Since astrocytes are present throughout all subtypes of MS lesions [41, 42] and IFNγ is present at all stages of MS [43], we further explored the transcriptional control of IFNγ signaling in astrocytes. This evidence concerns the gene IFNG and myeloid sarcoma.